Panbela Therapeutics, Inc.
PBLA
$0.2603
-$0.0607-18.91%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.91M | -28.57M | -27.27M | -25.26M | -23.52M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 41.00K | -540.00K | 576.00K | 661.00K | 878.00K |
| Change in Net Operating Assets | 12.30M | 8.98M | 1.80M | -647.00K | -4.53M |
| Cash from Operations | -15.57M | -20.13M | -24.89M | -25.25M | -27.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 775.00K | 1.18M | 400.00K | 400.00K | 400.00K |
| Cash from Investing | 775.00K | 1.18M | 400.00K | 400.00K | 400.00K |
| Total Debt Issued | 2.20M | -- | -- | -- | -- |
| Total Debt Repaid | -1.00M | -1.00M | -1.00M | -1.65M | -1.65M |
| Issuance of Common Stock | 13.78M | 13.78M | 22.29M | 29.95M | 31.29M |
| Repurchase of Common Stock | -27.00K | -46.00K | -25.00K | -29.00K | -28.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -924.00K | -924.00K | -1.75M | -2.12M | -2.87M |
| Cash from Financing | 14.03M | 11.81M | 19.52M | 26.14M | 26.74M |
| Foreign Exchange rate Adjustments | 2.00K | -3.00K | -3.00K | 0.00 | -4.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -765.00K | -7.15M | -4.97M | 1.29M | -34.00K |